Nanjing Leads Biolabs Co. Ltd. will hold an extraordinary general meeting on December 17, 2025, in Nanjing, the People's Republic of China. During the meeting, shareholders will consider and vote on several special resolutions, including the proposed adoption of the H Share Award Scheme and the proposed authorization to the Board and/or the Delegatee to handle matters related to the H Share Award Scheme.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251128-11933499), on November 28, 2025, and is solely responsible for the information contained therein.
Comments